Advertisement
Australia markets open in 8 hours 41 minutes
  • ALL ORDS

    8,132.10
    +49.80 (+0.62%)
     
  • AUD/USD

    0.6678
    -0.0017 (-0.25%)
     
  • ASX 200

    7,863.70
    +49.30 (+0.63%)
     
  • OIL

    80.07
    +0.01 (+0.01%)
     
  • GOLD

    2,426.90
    +9.50 (+0.39%)
     
  • Bitcoin AUD

    100,584.18
    +474.17 (+0.47%)
     
  • CMC Crypto 200

    1,365.00
    +10.58 (+0.78%)
     

GoodRx stock slides after mixed earnings report

GoodRx (GDRX) shares are sliding after the company’s latest earnings report fell below analyst estimates. Yahoo Finance Senior Reporter Anjalee Khemlani joins Catalysts to break down GoodRx's earnings and how the mixed results are weighing on the company's stock valuation.

While revenues are up year-over-year, the company missed on earnings per share. GoodRx also saw its general subscriptions decline 6% amid a lawsuit and a decrease in its savings plan with Kroger.

However, there have been some increases, especially in the company’s integrated savings program. GoodRx has partnered with major insurers to automatically apply savings to patient prescriptions.

For more expert insight and the latest market action, click here to watch this full episode of Catalysts.

ADVERTISEMENT

This post was written by Melanie Riehl

Video transcript

Taking a look at some of the other trending tickers here.Good Rx shares down this morning after the drug pricing comparison software company posted its latest earnings report coming in below analyst estimates for more.We've got our very own angel.That's right, man.We know that Good Rx has been under pressure for the last year or so.Really, looking at the subscriptions has been a key part of that.While revenues are up year over year, they did miss on earnings per share.But meanwhile, looking at what the core business is, UH, there have been some increases, such as the integrated savings programme.The company has now linked up with major insurers like CVS and Cigna, but has not, not with United Health, notably in order to allow those pharmacy benefits managers to automatically apply good Rx savings to to patients prescriptions.That's been one area of growth for the company.Meanwhile, the general subscriptions that the company had they have seen a 6% decrease year over year from 200 sorry, 22.6 million to now to 24.1 million, and that is in large part due to Kroger that has been one of the key areas that has pressured the company for the past couple of years.Of the decrease in that savings plan with those Kroger members, there's even a lawsuit that's been filed against them so that there's been a lot of problems with that area, but speaking sort of flat.We know the markets responding poorly, down 7% already in the day.But the company has been up year over year right now in the past year, up more than 50%.And in the year to date, more than 20% 25%.So, you know, sort of mixed signals on the stock right now.Some of them maybe just a valuation questions and at this point, and thanks so much.